1. Introduction {#sec1}
===============

Diabetes mellitus (DM) is a chronic disease involving metabolic disorder with the characterization of long-term hyperglycemia. The number of diabetic patients has been increasing around the world in recent years \[[@B1]\]. There are more than 382 million people worldwide suffering from diabetes currently, and this figure has been projected to increase to 592 million by 2035 \[[@B2]\]. There are three main types of diabetes mellitus, namely, type 1 DM (T1DM), type 2 DM (T2DM), and gestational diabetes. In particular, cases of T2DM have been rising compared with cases of T1DM, an autoimmune disease that causes the destruction of islet beta cells and the inability of producing insulin. Hyperglycemia, insulin resistance, and obesity are common features in T2DM. The coexistence of these diseases is typically a case of metabolic syndrome, leading to possible cardiovascular disease \[[@B3], [@B4]\].

*Psidium guajava* L. (Myrtaceae) is native to tropical areas, such as the Caribbean, Central America, and South America \[[@B5]\]. *P. guajava* L. is highly regarded as a medical plant all over the world. Some earlier studies have reported on the effects of *P. guajava* L. for the treatment of gastroenteritis, dysentery, and diarrhea, and leaf extracts have also been reported to show biological activities, including antidiarrheal, antimicrobial, antioxidant, anti-inflammatory, antiallergy, antiplasmodial, antispasmodic, antidiabetic, antinociceptive, and antitussive activities \[[@B6], [@B7]\]. *P. guajava* L. leaves are widely used to treat DM and hypertension in South Africa \[[@B8]\] besides oriental countries \[[@B9], [@B10]\]. Additionally, researchers often pay attention to *P. guajava* L. leaves as a folk remedy for diabetes. Pharmacological compounds of *P. guajava* L. leaves contain tannins \[[@B11]\], flavonoids \[[@B12]\], carotenes \[[@B13]\], and various terpenoids \[[@B14], [@B15]\].

Amino acids are basic units that consist of protein, and their normal metabolism is one of the important foundations of life activities. Systemic histiocytes undergo amino acid metabolism and participate in protein synthesis through deamination, decarboxylation, ammonia metabolism, oxidative decomposition, etc. Amino acid metabolism occurs mainly through the liver, kidneys, and muscles. These tissues and organs all have an important influence on the amino acid metabolism library in the body. Defects in proteins and enzymes involved in amino acid metabolism, including some pathological conditions, result in changes in amino acid metabolism and serum amino acid profiles. The pathogenesis of diseases and the mechanism of action of drugs can be predicted, diagnosed, and studied by measuring the concentration of amino acids in human body fluids such as plasma, urine, and sweat \[[@B16]--[@B18]\]. Amino acid metabolic profiling can also be used to study the mechanism of T2DM, and potential diagnostic models were evaluated by characteristic curve analysis. Five amino acids (lysine, aspartic acid, threonine, methionine, and alanine) and two lipids (low-density lipoprotein cholesterol and high-density lipoprotein cholesterol) were found to be potential biomarkers of T2DM \[[@B19]\].

The aim of this study was to investigate the antihyperglycemic and antihyperlipidemic effects of *P. guajava* L. leaf extracts in T2DM rats. Through analyzing the changes in plasma amino acid profiles of type 2 diabetic rats treated by *P. guajava* L. leaf extracts and the correlation analysis of pharmacodynamics results, the pathway and the molecular mechanism of the hypoglycemic activity of *P. guajava* L. leaf extracts for type 2 diabetes were discussed. Therefore, we can provide a reference for the treatment of diabetes.

2. Materials and Methods {#sec2}
========================

2.1. Reagents {#sec2.1}
-------------

Streptozotocin, amino acid standard solution (AAS18), and 6-aminocaproic acid were provided by Sigma-Aldrich (St. Louis, MO, USA). Citric acid monohydrate and trisodium citrate dihydrate were produced by Xilong Scientific Co., Ltd. (Guangdong, China). Glipizide tablets were supplied by Haikou Qili Pharmaceutical Co., Ltd. (Hainan, China). Chloral hydrate was obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). 4-Fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) was provided by Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Methanol (HPLC-grade) and acetonitrile (HPLC-grade) were purchased from Fisher Scientific, Ltd. (Rathburn, Walkerburn, UK). Trifluoroacetic acid (TFA), hydrochloric acid, and sodium hydroxide were obtained from Merida Technology Co., Ltd. (Beijing, China). Water was obtained from a Milli-Q water purification system (Bedford, USA). All other reagents were of analytical grade. All the biochemical analysis kits were purchased from Nanjing Jiancheng Bioengineering Institute.

2.2. Preparation of *P. guajava* L. Leaf Extracts {#sec2.2}
-------------------------------------------------

The *P. guajava* L. leaves were collected from Haidian Island (Haikou, China) on November 7, 2017. After collection, the plant was taxonomically identified and authenticated by Professor Yingxia Zhang, and voucher specimens (No. HDYX045) were deposited in the Herbarium of Medicinal Plants, Department of Pharmaceutical Sciences, School of Life and Pharmaceutical Sciences, Hainan University. The freshly collected *P. guajava* L. leaves were shade-dried. The dried *P. guajava* L. leaves were crushed with a stirrer, weighed, and mixed with 5 times the amount of distilled water, and then, extracts were leached at 60°C for 48 hours. The extracts were filtered by 20 layers of gauze, and the leaves were repeatedly extracted three times. The three filtrates were collected and filtered by a G3 glass sand funnel. The filtrate was concentrated in a 60°C water bath; then, the concentrated viscous extracts were dried in a 60°C oven; the dried *P. guajava* L. leaf extracts (GLE) were ground into powder, packed in a brown bottle, and placed in a dry box.

2.3. LC-MS/MS Analysis of *P. guajava* L. Leaf Extracts {#sec2.3}
-------------------------------------------------------

A Thermo Ultimate 3000 UHPLC (Waltham, MA, USA) was used for this method. The chromatographic separations were carried out using a waters BEH C18 (2.1 × 150 mm, 1.7 *μ*m) column at 45°C, with a mobile phase composed of water containing 0.1% acetic acid (*A*) and acetonitrile containing 0.1% formic acid (*B*). The gradient elution condition was as follows: 5% *B* (0-1 min), 5%--85% *B* (1--23.5 min), 85%--96% *B* (23.5--24 min), and 96% *B* (24--26 min). The flow rate was set at 0.4 mL·min^−1^ and the injection volume was 10 *μ*L.

A Thermo Q-Exactive plus High-Resolution UHPLC/MS system (Q-TOF X500R, AB Sciex, Foster City, CA, USA) equipped with a heat electrospray ionization (HESI) was used for this analysis. Q-Exactive plus HRMS was scanned with the mass ranges *m*/*z* 70--1050 in both positive and negative ion modes. Spray voltage was set as +3.8 kV in positive ion mode and −3.0 kV in negative ion mode, respectively. The other conditions were illustrated as follows: capillary temperature: 320°C; sheath gas flow rate: 35 arb; aux gas heater temperature: 350°C; aux gas flow rate: 8 arb; S-lens RF level: 50 V; full ms resolution: 70000; MS/MS resolution: 17500; TopN: 5; NCE/stepped NCE: 20, 40.

2.4. Animals {#sec2.4}
------------

Male SD rats were purchased from the Guangdong Medical Laboratory Animal Center (Guangdong, China). The rats were kept and maintained under laboratory conditions of temperature and light at 24°C and 12 h light/dark cycle, respectively. The experiment and the procedures were approved by the Animal Ethics Committee of Research Center for Drug Safety Evaluation of Hainan Province.

After one month of a high glucose and high fat diet, experimental diabetes was induced by an intraperitoneal injection of streptozotocin at 60 mg/kg body weight (STZ from Sigma, Beijing, China), dissolved in freshly prepared 0.1 M citrate buffer (pH of 4.0) in overnight fasted rats. The controls were treated with equivalent citrate buffer after one month of a standard diet. Five to seven days later, when the condition of diabetes was stabilized, animals were fasted for 8 h; then blood samples were taken from their tail veins and the plasma glucose concentration was measured by a blood glucose meter. Rats with blood glucose concentrations above 11.1 mmol/L and below 33.3 mmol/L were selected for the study.

2.5. Biochemical Analysis {#sec2.5}
-------------------------

One hour after the intragastric administration on the 18th day, each group of rats was given a glucose solution at 2 g/kg body weight. Blood samples were taken from tail veins at 0, 0.5, 1, and 2 hours in order to measure the blood sugar of rats in each group. The area under the blood sugar curve of the rats in each group was calculated according to the blood sugar values at four time points by using the following equation:$$\begin{matrix}
{\text{AUC}\left( {\text{mmol} \cdot {\text{h}/\text{L}}} \right) = \left( {A + B} \right) \times 0.25 + \left( {B + C} \right) \times 0.25 + \left( {C + D} \right) \times 0.5,} \\
\end{matrix}$$where *A*, *B*, *C*, and *D* represent blood glucose levels at 0, 30, 60, and 120 min, respectively.

After 20 days of gavage, the rats were anesthetized with 10% chloral hydrate solution at 3.5 mL/kg. The abdominal aortic blood was dissected to obtain 3--4 mL, and the serum was separated by centrifugation at 4500 r/min for 20 minutes. The glycosylated serum protein (GSP) content was determined by the fructose amine method, the total cholesterol (TCH) was determined by the cholesterol oxidase-peroxide coupled enzyme (COD-PAP) method, and the triglyceride (TG) content was determined by the glycerol phosphate oxidase-peroxide coupled enzyme (GPO-PAP) method. Red blood cells were used to prepare lysed blood, and the contents of glycated hemoglobin (GHb), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were determined by the kit.

2.6. Experimental Design {#sec2.6}
------------------------

*P. guajava* L. leaf extracts, glipizide, and distilled water were administered orally to experimental rats during the course of 20 days. Animals were randomly divided into four equal groups of 4 rats each as follows.Healthy control group: normal rats were given distilled water orally.Model group: diabetic rats were given distilled water orally.Positive control group: diabetic rats were given glipizide daily at a dose of 5 mg/kg body weight.GLE-treated group: diabetic rats were supplemented daily with *P. guajava* L. leaf extracts at a dose of 800 mg/kg body weight.

At 20 days, rats were measured for their blood sugar, taking the blood of the tail vein after intragastric gavage, following fasting for 2 h. Plasma was isolated for amino acid analysis. Each sample was analyzed in triplicate.

A fluorescence derivatization procedure and pretreatment of rat plasma samples were performed according to our previous reports \[[@B20]\]. Approximately 500 *μ*L of the SD rat\'s blood was placed in an anticoagulant tube, kept in a refrigerator at 4°C for 30 min, and then centrifuged at 8000 r/min for 15 min. The supernatant was taken and stored frozen at −80°C until analysis. Forty microliters of plasma sample and 40 *μ*L of an internal standard solution (0.1 mM 6-aminocaproic acid) were added to 160 *μ*L of methanol, 160 *μ*L of acetonitrile. After the mixture was centrifuged at 5000 r/min for 5 min, 20 *μ*L of the supernatant was evaporated to dryness under reduced pressure for 1 h. Then, the residue was added to 180 *μ*L of 0.2 M borate buffer solution (pH 8.5). 40 *μ*L of 10 mM NBD-F was added and the mixture was heated in a water bath at a temperature of 60°C for 5 min. After cooling the reaction mixture in ice water, 240 *μ*L of a 100 mM HCl solution was added to the reaction mixture. The resultant solution was injected into the HPLC system. An HPLC system equipped with a Waters 1525 pump and 2489 detector (Milford, USA) was utilized. The separation of amino acids was carried out on an Agilent Poroshell HPH-C18 column (3 × 150 mm, 2.7 *μ*m). The flow rate was maintained at 0.4 mL/min, with UV detection at 472 nm \[[@B21]\]. The column temperature was kept at 30°C. The injection amount was 5 *μ*L. Mobile phase *A* was H~2~O/CH~3~CN/TFA (90/10/0.12, v/v/v), and mobile phase *B* was H~2~O/CH~3~CN/TFA (10/90/0.12, v/v/v). The gradient elution program of the mobile phases was shown as follows: 100% (*A*) from 0 to 10.5 min, 100--70% (*A*) from 10.5 to 12.0 min, 70% (*A*) from 12.0 to 15.0 min, 70--58% (*A*) from 15.0 to 22.0 min, 58--0% (*A*) from 22.0 to 23.0 min, 0% (*A*) from 23.0 to 24.0 min, and 0--100% (*A*) from 24.0 to 24.1 min.

3. Results and Discussion {#sec3}
=========================

3.1. Analysis of Constituents in *P. guajava* L. Leaf Extracts {#sec3.1}
--------------------------------------------------------------

*P. guajava* L. leaf extracts were analyzed with UHPLC-Q-TOF-MS/MS in both positive and negative ion modes. The representative basic peak chromatograms (BPCs) corresponding to positive and negative signals of *P. guajava* L. leaf extracts are shown in [Figure 1](#fig1){ref-type="fig"}. The retention time, molecular weights, and fragment ions of identified compounds are listed in [Table 1](#tab1){ref-type="table"}. Finally, a total of 26 constituents were identified ([Table 1](#tab1){ref-type="table"}).

3.2. Biomedical Results {#sec3.2}
-----------------------

The biomedical characteristics of healthy control, model, positive control, and GLE-treated groups including body weight, glycosylated hemoglobin, serum insulin, serum triglycerides, serum total cholesterol, HDC-C, LDL-C, glycosylated serum protein, and glucose tolerance were determined. The fasting plasma glucose of the GLE-treated group (21.67 ± 5.67 mmol/L) was lower than that of the model group ([Table 2](#tab2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}). Besides, the ANCOVA analysis showed that total cholesterol, LDL-C, and glycosylated serum protein in the GLE-treated group were significantly reduced as compared with the model group (*p* \< 0.05). These results indicated that GLE possesses antihyperglycemic and antihyperlipidemic effects.

3.3. Multivariate Statistical Analysis {#sec3.3}
--------------------------------------

Amino acids in rat plasma samples were separated and determined by HPLC. The concentrations of amino acids in the rat plasma samples were analyzed ([Table 3](#tab3){ref-type="table"}). The data were normalized with MetaboAnalyst 4.0, and then principal component analysis (PCA) was performed to obtain the score vectorgraph of amino acid profiles of rat plasma in each group. The similarities and intergroup differences between the plasma samples of the four groups of rats were observed preliminarily through the established PCA model. The differences between samples were maximized by the PCA model ([Figure 3](#fig3){ref-type="fig"}), while it is not possible to distinguish whether the differences originate from intergroup or intragroup relationships.

The orthogonal partial least squares discriminant analysis (OPLS-DA) model was established to fully extract the differences between groups. Before the OPLS-DA model is used for analysis, it is necessary to set up the actual sample groups and perform a general analysis for two groups, in order to enhance the interpretation ability and classification performance of the model. Therefore, the OPLS-DA models of the model group and the drug-administered groups were established ([Figure 4](#fig4){ref-type="fig"}). The aggregation of groups and the dispersion of intergroup differences were increased by comparing with the PCA model, indicating that the model group and the drug-administered groups can be better distinguished by using the OPLS-DA model.

3.4. Screening of Pharmacological Markers {#sec3.4}
-----------------------------------------

In order to find potential amino acid biomarkers for the treatment of T2DM with *P. guajava* L. leaf extracts, the amino acid (VIP \>1) models were selected as characteristic metabolites, which were obtained by the OPLS-DA model ([Table 4](#tab4){ref-type="table"}). VIP means the variable importance in projection (VIP) score. VIP was used for the calculation of the importance of variables in the model, and the overall contribution of each variable to the model is described, usually with a threshold of VIP \>1.

The characteristic metabolites were introduced into the MetaboAnalyst 4.0 database in order to analyze metabolic pathways and find related metabolic pathways. As can be seen in [Figure 5](#fig5){ref-type="fig"}, dots represent the corresponding metabolic pathways, and colors represent the *p* values of the metabolic pathways. The redder the color, the larger the −log(*p*); in other words, P is smaller. The radius of the dot represented the Impact value of the metabolic pathway: the larger the radius, the greater the Impact. As indicated in [Figure 4](#fig4){ref-type="fig"} and [Table 5](#tab5){ref-type="table"}, the administration of *P. guajava* L. leaf extracts was associated with metabolic pathways in T2DM rats, such as cysteine and methionine metabolism, valine, leucine, and isoleucine biosynthesis, and phenylalanine, tyrosine, and tryptophan biosynthesis. The Impact values of cysteine and methionine metabolism, valine, leucine, and isoleucine biosynthesis, phenylalanine metabolism, glycine, serine, and threonine metabolism, and histidine metabolism were greater than 0.10, which indicated that these amino acid metabolic pathways are significant for the hypoglycemic activity of *P. guajava* L. leaf extracts.

4. Conclusions {#sec4}
==============

In this study, the blood glucose of T2DM rats decreased after they were treated with *P. guajava* L. leaf extracts. Through the analysis of amino acid profiling following 20 days of gavage administration, the concentration data were analyzed by principal component analysis and orthogonal partial least squares discriminant analysis to find the biomarkers and related metabolic pathways. Among these metabolic pathways, cysteine and methionine metabolism, valine, leucine, and isoleucine biosynthesis, phenylalanine metabolism, glycine, serine, and threonine metabolism, and histidine metabolism were found to be significant for the hypoglycemic activity of *P. guajava* L. leaf extracts.

This work was supported by the Key Science and Technology Project of Hainan Province (ZDYF2018110), grants from the Hainan Provincial Department of Education (Hnky2018-13), and the National Natural Science Foundation of China (21505029). The authors also express their sincere gratitude to Kobayashi International Scholarship Foundation.

Data Availability
=================

The data used to support the findings of this study are available from the corresponding author upon request.

Disclosure
==========

Chang Xu and Xin Li are the co-first authors.

Conflicts of Interest
=====================

The authors declare no conflicts of interest.

Authors\' Contributions
=======================

Yanting Song and Chang Xu conceived and designed the study; Chang Xu, Ying Liu, Debin Zeng, and Yuhang Gao performed the experiments; Chang Xu, Xi Xie, Rong Wang, and Lu-shuang Li participated in data collecting and statistical analysis; Yanting Song, Yingxia Zhang, Shiming Deng, and Makoto Tsunoda were project administrators; Chang Xu, Xin Li, Yuhang Gao, and Yanting Song wrote and revised the manuscript. Chang Xu and Xin Li contributed equally to this work.

![The basic peak chromatograms (BPCs) of *P guajava* L. leaf extracts in the negative ion mode (a) and in the positive ion mode (b).](ECAM2020-9784382.001){#fig1}

![Effect of *P. guajava* L. leaves on glucose tolerance in type 2 diabetic rats.](ECAM2020-9784382.002){#fig2}

![Principal component analysis (PCA) score plot based on the amino acid profiling of the rat plasma samples collected from the healthy control (green), model (dark blue), positive control (light blue), and GLE-treated groups (red).](ECAM2020-9784382.003){#fig3}

![Orthogonal partial least squares (OPLS) score plot of amino acid profiling in the rat plasma samples collected from the model (green) and GLE-treated (red) groups.](ECAM2020-9784382.004){#fig4}

![Effect of *P. guajava* L. leaf extracts on amino acid metabolic pathways in type 2 diabetes mellitus rats.](ECAM2020-9784382.005){#fig5}

###### 

Identification of the chemical compounds of *P guajava* L. leaf extracts by UPLC-Q-TOF-MS/MS.

  ------------------------------------------------------------------------------------------------ ---------- ------------------------ ------------------- ------------------------------
  Identification of the chemical compounds of *P. guajava* L. leaf extracts in negative ion mode                                                           
  Identification                                                                                   RT (min)   \[M − H\]^−^ (*m*/*z*)   Molecular formula   Fragment ions (*m*/*z*)^*a*^
                                                                                                                                                           
  Malic acid                                                                                       0.839      133.014                  C~4~H~6~O~5~        115, 89, 72, 71, 59
  Gallocatechin                                                                                    2.891      305.065                  C~15~H~14~O~7~      219, 167, 165, 137, 125
  Gossypetin                                                                                       2.895      479.086                  C~21~H~20~O~13~     319, 275, 225, 203, 110
  3,4-Dihydroxybenzoic acid                                                                        4.365      153.019                  C~7~H~6~O~4~        109, 108
  4-Hydroxybenzoic acid                                                                            4.423      137.024                  C~7~H~6~O~3~        108, 93, 65
  Coumaric acid                                                                                    4.620      163.040                  C~9~H~8~O~3~        119
  Rutin                                                                                            6.186      609.149                  C~27~H~30~O~16~     285, 284, 255
  Isoquercitrin                                                                                    6.447      463.087                  C~21~H~20~O~12~     301, 300, 271, 255
  Avicularin                                                                                       6.927      433.076                  C~20~H~18~O~11~     301, 300, 271, 255, 243
  Kaempferol-3-*O*-glucoside                                                                       7.104      447.095                  C~21~H~20~O~11~     284, 255, 227
  Myricetin                                                                                        7.560      317.030                  C~15~H~10~O~8~      178, 151, 137, 109
  Kaempferol                                                                                       10.175     285.040                  C~15~H~10~O~6~      165, 153, 121
                                                                                                                                                           
  Identification of the chemical compounds of *P. guajava* L. leaf extracts in positive ion mode                                                           
  Identification                                                                                   RT (min)   \[M + H\]^+^ (*m*/*z*)   Molecular formula   Fragment ions (*m*/*z*)^*a*^
  Ellagic acid                                                                                     0.904      303.013                  C~14~H~6~O~8~       285, 275, 257, 201
  Gallic acid                                                                                      1.180      171.028                  C~7~H~6~O~5~        107, 81, 79, 53, 51
  Epicatechin                                                                                      3.553      291.085                  C~15~H~14~O~6~      203, 137, 125, 123, 109
  Catechin                                                                                         4.449      291.086                  C~15~H~14~O~6~      147, 139, 123
  Genistein                                                                                        4.585      271.060                  C~15~H~10~O~5~      215, 153, 149, 141
  Procyanidin B2                                                                                   4.894      579.149                  C~30~H~26~O~12~     409, 287, 139, 127, 123
  Chlorogenic acid                                                                                 5.078      355.101                  C~16~H~18~O~9~      193, 179, 123, 105, 77
  Ferulic acid                                                                                     6.025      195.064                  C~10~H~10~O~4~      149, 145, 134, 117, 89
  Quercetin-3-*O*-galactoside                                                                      6.294      465.101                  C~21~H~20~O~12~     303, 229, 153, 85, 61
  Quercetin                                                                                        6.300      303.048                  C~15~H~10~O~7~      257, 229, 153, 137
  Tamarixetin                                                                                      7.134      317.065                  C~16~H~12~O~7~      302, 285, 229, 153
  Caffeic acid                                                                                     7.786      181.049                  C~9~H~8~O~4~        145, 135, 117, 89, 63
  Morin                                                                                            8.817      303.048                  C~15~H~10~O~7~      257, 229, 153, 137
  Formononetin                                                                                     13.998     269.080                  C~16~H~12~O~4~      120, 105, 77, 53, 51
  ------------------------------------------------------------------------------------------------ ---------- ------------------------ ------------------- ------------------------------

###### 

Biomedical characteristics of healthy control, model, positive, and GLE-treated groups.

                                        Healthy control group   Model group           Positive control group   GLE-treated group
  ------------------------------------- ----------------------- --------------------- ------------------------ ----------------------
  Body weight (g)                       430.18 ± 22.37          262.77 ± 12.38^*a*^   366.16 ± 16.55^*ab*^     336.24 ± 23.27^*ab*^
  Fasting blood glucose (mmol/L)        6.88 ± 0.36             24.80 ± 4.68^*a*^     18.63 ± 6.13^*ab*^       21.67 ± 5.67^*a*^
  Triglyceride (mmol/L)                 1.66 ± 0.77             2.84 ± 0.11^*a*^      2.61 ± 0.30^*a*^         2.79 ± 0.07^*a*^
  Total cholesterol (mmol/L)            2.29 ± 0.09             4.80 ± 0.40^*a*^      2.38 ± 0.58^*b*^         4.05 ± 0.19^*ab*^
  HDL cholesterol (mmol/L)              2.76 ± 0.76             1.75 ± 0.21^*a*^      1.77 ± 0.84^*a*^         2.00 ± 0.69^*ab*^
  LDL cholesterol (mmol/L)              0.10 ± 0.56             0.66 ± 0.06^*a*^      0.31 ± 0.37^*ab*^        0.51 ± 0.68^*ab*^
  Glycosylated hemoglobin (mmol/L)      13.23 ± 2.12            19.47 ± 4.33^*a*^     14.26 ± 4.23^*b*^        18.32 ± 2.35^*a*^
  Glycosylated serum protein (mmol/L)   1.24 ± 0.14             1.79 ± 0.18^*a*^      1.36 ± 0.13^*b*^         1.47 ± 0.16^*ab*^

Values are means ± standard deviation number of rats. ^*a*^*p* value indicates that the difference between the current group and the healthy control group was less than 0.05. ^*b*^*p* value indicates that the difference between the current group and the model group was less than 0.05.

###### 

The contents of amino acids in healthy control, model, positive, and GLE-treated groups.

        Healthy control group (*μ*mol/L) (*n* = 4)   Model group (*μ*mol/L) (*n* = 4)   Positive control group (*μ*mol/L) (*n* = 4)   GLE-treated group (*μ*mol/L) (*n* = 4)
  ----- -------------------------------------------- ---------------------------------- --------------------------------------------- ----------------------------------------
  His   37.9 ± 0.9                                   38.88 ± 0.67                       31.19 ± 0.44                                  47.07 ± 1.06
  Asn   34.7 ± 12.63                                 49.97 ± 6.51                       27.99 ± 8.26                                  50.31 ± 8.87
  Gln   428.66 ± 63.89                               259.76 ± 13.07                     179.44 ± 44.9                                 429.33 ± 128.92
  Ser   104.74 ± 14.8                                91.77 ± 2.12                       67.43 ± 16.44                                 102.33 ± 12.36
  Arg   48.87 ± 8.59                                 38.45 ± 18.3                       43.95 ± 2.65                                  25.66 ± 5.15
  Gly   280.25 ± 43.87                               95.54 ± 19.69                      205.3 ± 37.14                                 206.85 ± 6.99
  Glu   44.53 ± 8.13                                 42.78 ± 33.24                      26.2 ± 2.26                                   25.54 ± 2.19
  Thr   143.33 ± 33.19                               161.25 ± 28.71                     97.71 ± 16.77                                 147.55 ± 34.94
  Ala   408.44 ± 38.8                                345.73 ± 96.12                     261.21 ± 33.34                                262.4 ± 30.53
  Pro   89.65 ± 19.1                                 131.28 ± 49.69                     72.98 ± 8.84                                  96.64 ± 9.44
  Met   18.91 ± 1.19                                 38.53 ± 9.86                       14.57 ± 2.76                                  21.16 ± 1.98
  Val   89.71 ± 18.4                                 192.09 ± 79.9                      139.47 ± 23.35                                96.48 ± 32.92
  Orn   11.27 ± 5.33                                 62.9 ± 32.42                       12.56 ± 3.29                                  168.72 ± 68
  Cys   52.72 ± 16.36                                29.71 ± 1.15                       48.84 ± 3.94                                  38.69 ± 2.76
  Lys   162.16 ± 13.92                               86.59 ± 5.12                       66.88 ± 1.98                                  121.93 ± 32.86
  Leu   87.18 ± 12.15                                176.97 ± 73.47                     137.26 ± 7                                    90.76 ± 18.1
  Phe   44.46 ± 5.74                                 43.95 ± 1.52                       48.94 ± 5.66                                  50.68 ± 4.52

###### 

VIP contents in the orthogonal partial least squares discriminant analysis (OPLS-DA) model.

  Amino acid   VIP
  ------------ ------
  His          1.46
  Cys          1.36
  Phe          1.13
  Gln          1.08
  Val          0.99
  Ser          0.86
  Pro          0.73
  Glu          0.55
  Asn          0.05
  Gly          1.45
  Met          1.21
  Orn          1.10
  Leu          1.01
  Lys          0.96
  Ala          0.82
  Arg          0.71
  Thr          0.35

###### 

Effect of *P. guajava* L. leaf extracts on amino acid metabolic pathways in T2DM rats.

  No.   Pathway name                                           *p*               −log(*p*)   Holm *p*   FDR        Impact
  ----- ------------------------------------------------------ ----------------- ----------- ---------- ---------- ---------
  1     Cysteine and methionine metabolism                     6.4026*E *−* *4   7.3536      0.010884   0.010884   0.22557
  2     Valine, leucine, and isoleucine biosynthesis           0.0222            3.8076      0.333      0.094351   0.33333
  3     Phenylalanine, tyrosine, and tryptophan biosynthesis   0.034516          3.3663      0.44871    0.097795   0.5
  4     Phenylalanine metabolism                               0.034516          3.3663      0.44871    0.097795   0.40741
  5     Primary bile acid biosynthesis                         0.06557           2.7246      0.72127    0.11147    0.02976
  6     Glycine, serine, and threonine metabolism              0.1508            1.8918      0.90481    0.1972     0.26884
  7     Glutathione metabolism                                 0.1508            1.8918      0.90481    0.1972     0.00955
  8     Histidine metabolism                                   0.32563           1.122       1.0        0.39541    0.24194
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